Morgan Stanley analyst Erin Wright downgrades Elanco Animal Health (NYSE:ELAN) from Overweight to Equal-Weight and lowers the price target from $37 to $22.
Morgan Stanley analyst Stephen Byrd downgrades Array Technologies (NASDAQ:ARRY) from Equal-Weight to Underweight and lowers the price target from $17 to $15.
Credit Suisse analyst Andrew Kligerman downgrades Principal Finl Gr (NASDAQ:PFG) from Outperform to Neutral and raises the price target from $82 to $86.